FDA Moves to Resume Use of J&J COVID Vaccine
FRIDAY, April 23, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Friday lifted the temporary pause it had placed on the Johnson & Johnson COVID-19 vaccine and said it will add a note to the shot’s labeling warning of the potential for rare blood clots. The moveContinue Reading